2025.03.25 / News

3SBio Unveils 2024 Annual Results: Profit Surges 34.9% YoY, Innovation Pipeline Delivers Strong Value

2024.08.22 / News

3SBio Unveils 2024 Interim Results: Revenue Up 16% YoY, Autoimmune Pipeline Poised for a Promising Phase

2024.03.20 / News

3SBio reveals 2023 annual results: Revenue surges by 13.8% year on year, with pipelines to reap the rewards

3SBio will remain steadfast in its role as a national biopharmaceutical leader

2023.03.21 / News

3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%

3SBio is committed to sharpening its focus on refined management and ensuring the healthy developmen...

2022.08.24 / News

3SBio announces 2022 interim results, with net profit attributable to owners of the parents continuing to grow despite COVID-19 and cash hitting new record high

with net profit attributable to owners of the parents continuing to grow despite COVID-19 and cash h...

2022.03.30 / News

3SBio announces 2021 annual results, with net profit attributable to owns of the parents almost doubling under accelerated growth of diversified businesses

3SBio announces 2021 annual results